Consistent with the recent description of constitutive BCMA shedding from the membrane of plasma cells by a γ-secretase (62), high serum BCMA level correlates with disease status and constitutes a valuable biomarker in multiple myeloma (63). The gene discussed is TNFRSF17; the disease is plasma cell myeloma.